Koers Jounce Therapeutics, Inc.
Aandelen
JNCE
US4811161011
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Kevin Tang
CEO | Chief Executive Officer | 57 | - |
Michael Hearne
DFI | Director of Finance/CFO | - | - |
Eric Laub
IRC | Investor Relations Contact | - | 01-09-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Kevin Tang
CEO | Chief Executive Officer | 57 | - |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 0 M€ | 0,00% | - | |
0.00% | 18 M€ | +3,41% | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,51% | 104 mld. | |
+3,22% | 97,42 mld. | |
+1,66% | 22,2 mld. | |
-16,53% | 21,23 mld. | |
-9,03% | 18,33 mld. | |
-42,33% | 16,35 mld. | |
-20,09% | 15,06 mld. | |
+5,47% | 13,98 mld. | |
+28,85% | 11,66 mld. |